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SEVERITY OF OSTEOARTHRITIS IN GLOBAL POPULATIONS
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Purpose: Understanding the distribution of the severity of hip and knee
OA within populations would enable planning for future health system
use and needs of the community. The aim of this study was to estimate
the severity of hip and knee OA within global populations.
Methods: As part of the Global Burden of Disease 2010 Study, lay
descriptions of mild, moderate and severe hip and knee OA were
developed. Mild OAwas described as a person who “Has pain in the leg,
which causes some difﬁculty running, walking long distances, and
getting up and down”; moderate OA “Has moderate pain in the leg,
which makes the person limp, and causes some difﬁculty walking,
standing, lifting and carrying heavy things, getting up and down and
sleeping” and severe “Has severe pain in the leg, which makes the
person limp and causes a lot of difﬁculty walking, standing, lifting and
carrying heavy things, getting up and down, and sleeping”. Between
October 2009 and June 2010 these lay descriptions were presented to
adults 18 years and over in household surveys in ﬁve countries (Ban-
gladesh, Indonesia, Peru, Tanzania and USA) and an open-access web-
based survey to establish disability weights (DWs). DWs reﬂect the
severity of each health state on a continuum between zero (equivalent
to full health) and one (equivalent to death). WOMAC scores were then
used to classify these levels of severity, with mild OA corresponding to a
score of 0 to 5, moderate>5 to 13 and severe>13 to 20. For this analysis,
having undergone joint replacement surgery was assumed to result in
‘mild’ OA. To determine the proportion of people with hip and knee OA
within each of the severity levels, ﬁve population-based studies con-
tained WOMAC data that could be categorised into the three severity
levels as described above. These data were from USA, Australia and
Bangladesh. Estimates of the proportions of OA cases with mild, mod-
erate and severe were pooled using Meta-XL, an excel add-in free-ware.
Results: The lay descriptions of hip and knee OA as presented in the
household and internet surveys resulted in DWs of 0.02 (95% UI: 0.01–
0.04) for mild, 0.08 (95% UI: 0. 05–0.12) for moderate and 0.17 (95% UI:
0.12–0.24) for severe OA. The pooled disability weight for high income
countries was 0.04 (95% UI: 0.03–0.06) and for low/middle income
countries 0.07 (95% UI: -0.05–0.1). The severity estimates varied
between high income and low/middle income countries but not by sex.
The proportion of the population within each of the severity levels are
shown in the table below, along with 95% Uncertainty Interval.
Conclusions: Population-based data on the severity of hip and knee OA
are largely lacking, with no severity data being available/reported for
most regions of the world. The DWs were unexpectedly low, with the
weight for severe OA being only 0.17. This could be due to difﬁculties in
incorporating all the disabling characteristics of severe OA within a
limited lay description. Further work on revising these lay descriptions
for future studies is recommended. The available data suggest that
within low andmiddle income countries, a greater proportion of people
are living with moderate to severe hip and knee OA than in high income
countries where a larger proportion are living with mild OA. For this
analysis, joint replacement surgery was assumed to result in mild OA.
Access to total joint replacement surgery would vary between high and
low income countries, so the proportion with mild OA would be
expected to be higher in high income countries than low-income.
Severity datawere not available over time, so changes in the population,
such as aging or an increase in obesity, were not able to be assessed. It is
important that future population-based studies assess the severity of
OA within different regions and over time. A standardised deﬁnition of
OA is needed so comparisons can be made between populations.364
FOR HOW LONG DO PEOPLE WITH OSTEOARTHRITIS SELF-MANAGE
BEFORE SEEKING PHYSICIAN CARE? SURVEY ON LIVING WITH
CHRONIC DISEASES IN CANADA FINDINGS
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Purpose: Self-management prior to seeking physician care is a key
period when people with early osteoarthritis (OA) can make lifestyle
choices aimed at reducing pain, improving function and slowing disease
progression, which could reduce resource use and burden on the
healthcare system. Measuring duration of self-management and asso-
ciated health resource use is important for resource planning; however,
it is not routinely captured in health administrative data at the pop-
ulation level. Our objective was to estimate the duration of self-man-
agement and associated health care utilization in the proportion of
respondents with OA, focusing on hip- and knee-related OA as the most
common joints affected, within the Canadian population.
Methods: Respondents were a nationally-representative sample of 4565
Canadians aged 20 years from the arthritis component of the 2009
Statistics Canada Survey on Living with Chronic Diseases in Canada, who
reported on their experience living with arthritis. We report the per-
centage of OA and hip-, knee-, or hip and knee-related OA. We estimate
mean age of symptom onset and diagnosis, proportion reporting medi-
cation use, contacts with health professionals and self-management
strategies over the prior 12 months. Estimates were weighted to repre-
sent the Canadian household population living with arthritis.
Results: Overall, 1755 (37%) respondents reported having OA (any joint)
and no other arthritis diagnosis. Of these, 70% experienced pain in the
hip(s), knee(s), or hip(s) and knee(s). The temporal sequence of OA
diagnosis and onset of pain varies across individuals. Nearly half (48.1%)
of individuals with OA ﬁrst experienced pain in their hip or knee in the
same year as their OA diagnosis, 41.6% experienced pain at least one
year prior to diagnosis, and 10.2% of individuals experienced pain fol-
lowing an initial diagnosis of OA. The number of years of self-man-
agement is most relevant among those who experienced pain prior to
an OA diagnosis. Among these individuals, the average number of years
of self-management was 7.7 years. This ﬁnding was consistent across
location of joint pain but varied across age groups, from 5.6 years
among those younger than 50 years of age to 10 years among those 65
or older. In the past year, most respondents used non-prescription
medications to manage symptoms (66%), fewer than 25% saw a phar-
macist or physiotherapist, and 12% attended an educational class.
Conclusions: Individuals with OA spend a considerable time period
self-managing their disease; almost a decade during which they have
the opportunity to reduce pain, improve function and slow disease
progression. This study ﬁlls an existing gap in our understanding of
treatment and self-management of OA which cannot be provided by
administrative data sources. Researchers and health care professionals
need to continue to develop and promote OA management strategies
that will help reduce disability associated with OA and advancing age.
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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S209Purpose: Non-steroidal anti-inﬂammatory agents (NSAIDs) are com-
monly used to manage symptoms in patients with knee osteoarthritis
(OA). While randomized controlled trials have demonstrated efﬁcacy,
real world effectiveness of these agents in long term studies is lacking.
This study sought to estimate the effectiveness of NSAIDs on symptom
management over 4 years among persons with radiographically con-
ﬁrmed OA. Marginal structural models, which take into consideration
the likely dual role of indices of disease severity as confounders and
intermediary variables, were compared to standard repeated-measure
analyses.
Methods: We identiﬁed NSAID naïve participants with radiographic
knee OA in the Osteoarthritis Initiative. Participants were evaluated
over 4 years. NSAID users included those reporting any use of pre-
scription medication use (i.e., either regular use or as-needed use) at
each assessment. Outcome measures included WOMAC Pain, Stiffness
and Physical Function. Beta coefﬁcients derived from marginal struc-
tural models and generalized estimating equation models represented
the average change in outcomemeasures attributed to long term NSAID
use. Minimally important clinical differences were a priori set as at least
1.2 for pain, 0.5 for stiffness, and 4.1 for function.
Results: Persons with radiographically conﬁrmed OA with long term
reports of prescription NSAIDS use experienced improvements in
WOMAC Pain: -0.99 (95% Conﬁdence Interval (CI): -2.38 to 0.4);
WOMAC Stiffness: -0.64 (95% CI: -1.52 to 0.24); and WOMAC Function:
-5.29 (95% CI: -9.7 to -0.89). In contrast, the analysis with generalized
estimating equations yields an estimate of -0.03, -0.08 and 0.07 for
difference in Pain, Stiffness and Function, respectively.
Conclusions: When evaluated using marginal structural models, long
term use of NSAIDs showed a modest trend towards relieving symp-
toms and a clinically signiﬁcant improvement in function in patients
with radiographically conﬁrmed OA, whereas a standard regression
models didn’t show such beneﬁts. Studies on the treatment of OA using
non-experimental data should consider using marginal structural
models when evaluating the overall treatment effect from a time-
varying treatment.
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PATIENT REPORTED OUTCOMES FOLLOWING PRIMARY HIP
REPLACEMENT SURGERY: DEVELOPMENT AND INTERNAL
VALIDATION OF A PROGNOSTIC TOOL
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Purpose: Although Total Hip Replacement (THR) is a successful surgical
intervention, there are a minority of patients who do not achieve
clinically meaningful improvement or whose symptoms get worse
following surgery. The aim of this study was to develop a clinical risk
prediction tool to predict patient reported outcomes following primary
hip replacement surgery.
Methods: We obtained data on two prospective cohorts of patients
receiving primary THR for osteoarthritis: Exeter Primary Outcomes
Study (n ¼ 1247); EUROHIP (n ¼ 845). The primary outcome was the
Oxford Hip Score (OHS). Combining data from two large prospective
cohort studies allowed us to take account of a wide and comprehensive
range of both traditional and novel risk factors, including patient,
radiographic and surgical predictors. Linear regression modelling was
used to identify predictors of outcome. For internal validationwe used a
combination of multiple imputation and bootstrapping with backward
selection. Performance of the predictive model was assessed in terms of
calibration and discrimination.
Results: Of the radiographic variables pattern of OA was an important
determinant of outcome. Those with superomedial, medial or concen-
tric disease had worse outcomes than patients with a superolateral
pattern of OA or no reduction in joint space. Arthritis in other joints, and
previous surgery on other joints, were associated with worse outcomes.For surgical variables, a posterior surgical approach, and larger femoral
component offset had better outcomes. For patient factors, worse pre-
operative pain/function, increasing age when over age 75, increasing
BMI, lower levels of educational attainment and those with worse pre-
operative SF36 mental health scores, also had worse outcomes.
These factors were operationalized into a clinical risk prediction tool.
Calibration of the predicted 12-month post-operative OHS, and abso-
lute change in OHS was good. The model showed good discriminatory
ability with a bias corrected R-squared of 23.1%. We tested the ability of
the model to identify patients with the worst possible outcomes fol-
lowing THR (deﬁned as a change in OHS < 5-points of whom 89 (4.25%)
patients met this criterion). Performance of the tool to identify patients
with the worst outcomes was good (C-statistic 0.77 95%CI (0.72 to
0.82)).
Conclusions: We have developed a clinical risk prediction tool that
would provide information on the likely outcomes of hip replacement
surgery. Following hip replacement the majority of patients do very
well, and only a minority will not achieve clinically meaningful symp-
tomatic change in OHS. The clinical tool performed well in terms of its
calibration and discriminatory ability, and identiﬁcation of those
patients with the worst possible outcomes was good. The tool provides
individualised risk prediction and allows patients to understand their
expected outcomes of surgery – it has the potential to guide patient-
clinician decision-making. It will now undergo external validation in a
new prospective cohort of patients.
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COURSE OF PHYSICAL FUNCTIONING AND PAIN IN OSTEOARTHRITIS
OF THE KNEE OR HIP: A SYSTEMATIC REVIEW
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Purpose: (1) The aim of the study was to systematically summarize the
literature from March 2005 to January 2013 on the course of physical
functioning and pain in patients with OA of the knee or hip and (2) to
provide an overview of prognostic factors of physical functioning and
future pain for these patients.
Methods: A search was conducted in PubMed, CINAHL, Embase and
Psych-INFO in January 2013. Eligible studies were prospective cohort
studies (minimum follow up was  6 months) that included partic-
ipants with knee or hip OA diagnosed with radiographically and/or
